VALLEY NATIONAL ADVISERS INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3
-62.5%
7,655
-52.1%
0.00%0.0%
Q2 2023$8
-42.9%
15,9850.0%0.00%
-50.0%
Q1 2023$140.0%15,985
+89.6%
0.00%
-33.3%
Q4 2022$14
-99.9%
8,430
-33.3%
0.00%
-40.0%
Q3 2022$23,000
-14.8%
12,6300.0%0.01%
-16.7%
Q2 2022$27,000
-38.6%
12,630
+2.7%
0.01%
-25.0%
Q1 2022$44,0000.0%12,300
+38.2%
0.01%0.0%
Q4 2021$44,000
-48.2%
8,900
-25.2%
0.01%
-46.7%
Q3 2021$85,000
-34.1%
11,900
-14.4%
0.02%
-37.5%
Q2 2021$129,000
+18.3%
13,900
+18.8%
0.02%
+14.3%
Q1 2021$109,000
-21.6%
11,700
-25.5%
0.02%
-27.6%
Q4 2020$139,000
-23.6%
15,7000.0%0.03%
-31.0%
Q3 2020$182,000
-49.2%
15,700
+18.0%
0.04%
-48.8%
Q2 2020$358,000
+306.8%
13,300
+12.8%
0.08%
+241.7%
Q1 2020$88,000
+166.7%
11,796
+17.3%
0.02%
+200.0%
Q4 2019$33,000
+57.1%
10,0570.0%0.01%
+33.3%
Q3 2019$21,00010,0570.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders